Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. [electronic resource]
Producer: 20050321Description: 172-81 p. digitalISSN:- 0264-410X
- Adjuvants, Immunologic
- Adolescent
- Adult
- Cancer Vaccines -- immunology
- Cholesterol -- therapeutic use
- Drug Combinations
- Female
- Humans
- Immunotherapy
- Middle Aged
- Oncogene Proteins, Viral -- genetics
- Papillomaviridae -- immunology
- Papillomavirus E7 Proteins
- Papillomavirus Infections -- immunology
- Phospholipids -- therapeutic use
- Recombinant Fusion Proteins -- immunology
- Repressor Proteins -- genetics
- Saponins -- therapeutic use
- Uterine Cervical Dysplasia -- immunology
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.